Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

BACKGROUND: Approximately 40% of adults with Philadelphia chromosome-negative acute lymphoblastic leukemia achieve long-term survival following unrelated donor hematopoietic stem cell transplantation in first complete remission but severe graft-versus-host disease remains a problem affecting surviva...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Patel, Bella, Kirkland, Keiren E., Szydlo, Richard, Pearce, Rachel M., Clark, Richard E., Craddock, Charles, Liakopoulou, Effie, Fielding, Adele K., Mackinnon, Stephen, Olavarria, Eduardo, Potter, Mike N., Russell, Nigel H., Shaw, Bronwen E., Cook, Gordon, Goldstone, Anthony H., Marks, David I.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2009
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2754956/
https://ncbi.nlm.nih.gov/pubmed/19648167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.008649
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller